ESSA Pharma Inc. (EPIX)

ESSA Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Year Ending	Current	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	228	136	80	352	143	19
Market Cap Growth	186.80%	69.89%	-77.20%	145.62%	635.97%	345.80%
Enterprise Value	92	-12	-87	157	65	-30
PE Ratio	-	-5.13	-2.28	-9.56	-6.11	-1.53
PB Ratio	1.71	0.94	0.48	1.81	1.81	0.40
P/FCF Ratio	-17.54	-6.89	-2.86	-13.84	-8.44	-1.59
P/OCF Ratio	-17.54	-6.89	-2.86	-13.84	-8.44	-1.59
EV/EBITDA Ratio	-8.68	0.45	2.48	-4.28	-2.81	2.51
EV/EBIT Ratio	-8.65	0.45	2.47	-4.26	-2.80	2.51
EV/FCF Ratio	-11.20	0.61	3.11	-6.18	-3.81	2.48
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.08
Debt / EBITDA Ratio	-0.01	0.00	-0.01	-0.01	0.00	-0.31
Debt / FCF Ratio	-0.02	0.00	-0.01	-0.01	0.00	-0.30
Quick Ratio	32.67	42.48	72.50	49.79	65.58	9.68
Current Ratio	32.89	42.57	73.17	50.28	66.73	9.74
Interest Coverage	-10472.59	-3827.97	-2560.84	-1656.96	-37.40	-20.10
Return on Equity (ROE)	-19.50%	-17.30%	-19.90%	-21.90%	-36.60%	-43.90%
Return on Assets (ROA)	-19.00%	-17.00%	-19.50%	-21.40%	-34.70%	-36.10%
Return on Capital (ROIC)	-25.52%	-22.05%	-22.09%	-19.11%	-29.66%	-23.06%
Earnings Yield	-12.16%	-19.51%	-43.76%	-10.46%	-16.37%	-65.54%
FCF Yield	-9.39%	-14.52%	-34.91%	-7.22%	-11.85%	-62.93%
Buyback Yield / Dilution	-0.33%	-0.12%	-14.44%	-71.45%	-166.13%	-84.68%
Total Shareholder Return	-0.33%	-0.12%	-14.44%	-71.45%	-166.13%	-84.68%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).